Navigation Links
Henry Gabelnick receives lifetime achievement award
Date:5/27/2010

Arlington, VA (May 27, 2010) -- CONRAD is pleased to announce that Executive Director, Henry Gabelnick, Ph.D, was awarded the lifetime achievement award at the 6th International Microbicides 2010 Conference. This year's conference, Building Bridges to HIV Prevention, was held in Pittsburgh, Pennsylvania May 22-25 and before an audience of more than 1,000 HIV advocates and scientists, Dr. Gabelnick was recognized for his unparalleled commitment and dedication to the development of microbicides. The lifetime achievement award was his second in 2005, Dr. Gabelnick was recognized by the International Conference on AIDS India for a lifetime devoted to reproductive health.

"In a field with so many dedicated, brilliant and persistent researchers, I am tremendously honored to be singled out by my peers," said Dr. Gabelnick. His acceptance speech described his early years working in the chemical industry, specifically in the field of plastics, and his journey to more fulfilling work in the field of contraception and microbicides. Dr. Gabelnick received his undergraduate and graduate degrees at MIT and his doctorate from Princeton. After beginning his career in the chemical industry, Dr. Gabelnick moved to the Biomedical Engineering Branch of the National Institutes of Health. He joined CONRAD at its inception in 1986, and focused primarily on developing new methods of contraception until it became clear that HIV prevention was crucial to overall reproductive health. For the past 20 years, CONRAD has contributed to the microbicide development field through the development of preclinical algorithms and primate models, standardization of colposcopy techniques, biomarker research and clinical trials.

CONRAD scientists also presented the following study findings and analyses at various sessions during the conference:

  • Christine Mauck, M.D., M.P.H. - Assessing Markers of Inflammation after Vaginal Product Use: Nonoxynol-9, Cellulose Sulfate, and HEC Placebo Comparative Double-Blind Phase I Trial and Colposcopy: Still Useful in Microbicide Safety Trials?
  • Gustavo Doncel, M.D., Ph.D. - Combining HIV Prevention and Contraception Technologies
  • Mohammed Saifuddin, D.V.M., Ph.D. - Evaluation of 6% Cellulose Sulfate and 0.5% PRO2000 Gel Microbicide Efficacy in a Single-Dose Intravaginal R5+X4 SHIV Infection Model in Rhesus Macaques Pre-treated with Depo-Provera
  • Irina Zalenskaya, Ph.D. - Gene Expression Profile of Vaginal Epithelial Cells Exposed to Proinflammatory Agents - Identification of Novel Biomarkers of Mucosal Safety
  • Jill Schwartz, M.D. - Pilot Clinical Pharmacokinetic and Pharmacodynamic Study of UC781 Vaginal Gel


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Henry Ford Hospital study: Fewer infections with new heart-pump implant
2. Henry Ford Hospital: New left-side heart pump improves right-side heart function
3. Henry Ford Hospital study: Less prep needed for colonoscopy
4. Henry Ford Health System goes radical: Creating the hospital of the future
5. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
6. Henry Ford Hospital study: Shoulder function not fully restored after surgery
7. Henry Ford Hospital study shows link between vitamin D, skin cancer
8. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
9. National Press Club to Host NEWSMAKER Media Briefing on Cornhusker Kickback With South Carolina Attorney General Henry McMaster
10. iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems
11. Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Nashville, Tennessee (PRWEB) , ... ... ... leader in strategic interoperability, today announced that the company will provide alerting ... platform. CIHIE has been recently awarded $1.7 million in federal funds as ...
(Date:12/5/2016)... Shrewsbury, PA (PRWEB) , ... December 05, 2016 , ... ... of necessity for the betterment of both the smaller rider and the horse. Smaller ... performance. The Saddle Sidekick is designed to fit over a properly fitted western saddle ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... of physical therapist assistants, under direct supervision of a licensed physical therapist, to ... therapy receives a consultation and treatment plan from a licensed physical therapist (PT) ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Facial Rejuvenation" at the 2016 Anti-Aging & Beauty Awards at The Aesthetic ... Aesthetic & Anti-aging Medicine European Congress (AMEC) brings together the industry’s leading ...
(Date:12/4/2016)... California (PRWEB) , ... December 03, 2016 , ... ... lower thirds, 4 transitions and many more tools allowing FCPX editors to create ... of Pixel Film Studios. , Perfect Harmony contains a beautifully designed 3D ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... Calif. , Dec. 5, 2016 Sanovas, ... technology accelerator, announced today the launch of its wholly owned ... Logo - http://photos.prnewswire.com/prnh/20161202/445250LOGO   Logo - http://photos.prnewswire.com/prnh/20161202/445251LOGO ... ... There ...
(Date:12/5/2016)... Dec. 5, 2016  Wellbridge Health and Gateway Health proudly ... solutions to Medicare and Medicaid plan members with specific high ... the unique needs of this group of consumers, Wellbridge combines ... philosophies to provide insight into members, daily behaviors and lifestyle. ... , , ...
Breaking Medicine Technology: